Pomegranate Health Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.8/10
Best for: low-cost compounded semaglutide or tirzepatide with prices shown upfront and no membership required
Price is where Pomegranate Health scores best in our breakdown.
Semaglutide
Tirzepatide
Price checked on Pomegranate Health’s site,
What the monthly price covers
Medication
Included
Provider visits
Not stated
Shipping
Included
Lab work
Not stated
Coaching
Not stated
No insurance needed · Vetted by our editors
Telehealth provider with low-cost compounded semaglutide (from $129/mo) and tirzepatide (from $149/mo), priced publicly before intake, with no membership required.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
What is Pomegranate Health?
Pomegranate Health is an online clinic where licensed physicians can prescribe compounded semaglutide or tirzepatide, along with options like the Wegovy pill and Foundayo, after a quick online intake and virtual consultation. There's no membership requirement, and FSA and HSA cards are accepted. It suits people who want low-cost compounded GLP-1 medication and are comfortable paying cash.
Vetted alternatives to Pomegranate Health
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
from $129/mo (see plan details) · no insurance needed
Pomegranate Health at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $129/mo (see plan details)
- What's included
- Medication · Shipping
- FDA status
- No FDA warning letter on record
How we scored Pomegranate Health
Each dimension is scored algorithmically from Pomegranate Health’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
8.9/10At $129/mo (see plan details), Pomegranate Health runs about 28% below the $179 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide).
Effectiveness25%
8.4/10Pomegranate Health offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.2/10Online intake and platform experience; 3 platform features disclosed.
Trust & Safety15%
7.6/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
6.4/10Pomegranate Health's exact state footprint isn't published. Confirm coverage in your state before signing up.
Support10%
6.2/10Pomegranate Health provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Pomegranate Health review
Last checked October 2026- Confirmed current pricing across 4 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the provider's public sign-up flow, stopping before payment
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $129–$189/mo across 4 dose/plan tiers (checked October 2026)
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with Pomegranate Health
We walked Pomegranate Health’s public signup flow in July 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Complete a quick online intake questionnaire about health history, lifestyle, and goals.
- 2A licensed physician reviews your medical history and determines eligibility.
- 3If approved, the provider issues a prescription sent to a partner pharmacy.
- 4Medication (compounded semaglutide or tirzepatide) is shipped to your home.
- Monthly prices are shown on the public pricing page before intake (semaglutide from $129/mo, tirzepatide from $149/mo), and change with the dose tier and pharmacy.
- Intake is fully virtual with no stated live video-visit requirement.
- Labs are only requested in some cases (recent results within 12 months), not universally required.
- Offers compounded GLP-1 medications shipped to the patient.
- Support is available by phone and email with published hours.
Pomegranate Health customer support
- Phone
- 813-419-1189
- Hours
- Mon-Fri 7am-10pm EST; Sat-Sun 8am-5pm EST
GLP-1 medications Pomegranate Health offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
'$129/month' at the default pharmacy on the pricing page; other pharmacies show $99 to $129 at this tier. Pomegranate says it can't guarantee which pharmacy fills your order, and asking for a specific one adds a $150 coordination fee.
'$149/month' at the default pharmacy on the pricing page; other pharmacies show $119 to $149 at this tier. Pomegranate says it can't guarantee which pharmacy fills your order, and asking for a specific one adds a $150 coordination fee.
'$149/month' at the default pharmacy on the pricing page; other pharmacies show $139 to $199 at this tier. Pomegranate says it can't guarantee which pharmacy fills your order, and asking for a specific one adds a $150 coordination fee.
'$189/month' at the default pharmacy on the pricing page; other pharmacies show $169 to $249 at this tier. Pomegranate says it can't guarantee which pharmacy fills your order, and asking for a specific one adds a $150 coordination fee.
Ready to get started?
Plans and promotions change often, so check Pomegranate Health's current pricing and active discounts before you decide.
What we like
- Low published prices: compounded semaglutide from $129/mo and tirzepatide from $149/mo
- Prices are shown before you start the intake
- No membership required
- Support by phone, email and chat, seven days a week
Watch-outs
- Price depends on the dose tier and the pharmacy, and Pomegranate can't guarantee which pharmacy fills your order
- Choosing a specific pharmacy adds a $150 coordination fee
- Consultation and medication fees are nonrefundable
- Not available in California, Iowa or Wisconsin; Alaska, Hawaii and Puerto Rico orders carry a $60 shipping surcharge
- Problems with an order must be reported within 24 hours of delivery
Pomegranate Health: the price-first option for cost-driven shoppers
Pomegranate Health is a telehealth provider built around a single, blunt promise: some of the lowest compounded GLP-1 pricing you'll find anywhere. Its starting compounded semaglutide runs about $129 a month (see plan details), which lands well under the category median of $179. If your decision comes down almost entirely to monthly cost, Pomegranate is a candidate. But the same minimalism that keeps the price low also means the company publishes far less about itself than most rivals, and you give up that information in exchange for the price.
How we get the market median: $179 is the middle value of each program's lowest listed ongoing monthly price for compounded semaglutide (month to month, not a first-month promo, a prepaid plan or a price with a membership on top), across the 121 programs that publish one.
How the pricing works
Pomegranate sells compounded medication on a flat monthly basis, and the headline figure includes the drug itself plus shipping. The company says orders are "shipped discreetly to your door at no extra cost," so there's no separate delivery charge stacked on top. There is no teaser or first-month promo rate that later jumps, so the low number is the monthly price. Compounded tirzepatide costs more than the semaglutide tier, as it does at nearly every provider, but both sit at the aggressive end of the market.
One caveat on the math: pricing in this corner of telehealth moves, and Pomegranate's has already drifted upward once. Treat the figures here as a ballpark and confirm the live monthly cost (and exactly what's bundled into it) on the checkout page before you commit. See our scoring methodology for how we weigh price against everything else.
The medications and how they're dispensed
Pomegranate offers two compounded GLP-1s: semaglutide (the active ingredient in Wegovy and Ozempic) and tirzepatide (the molecule behind Zepbound and Mounjaro). Both are compounded rather than brand-name, which is what makes the low pricing possible: you are not paying a brand list price that can run well over a thousand dollars a month elsewhere. Medication and shipping are included in the monthly fee. For readers who put a needle-free option first, Somi Health adds an oral semaglutide tablet to its compounded injections at one price for any dose, but its partner pharmacies aren't named.
- Compounded semaglutide: the lowest-priced tier, around $129 a month (see plan details) with shipping included
- Compounded tirzepatide: a higher monthly cost, still priced aggressively for the dual-action molecule
- No brand-name option: if you specifically want FDA-approved Wegovy, Ozempic, Zepbound or Mounjaro, this isn't the provider for that
Pomegranate competes on price
Pomegranate competes almost purely on monthly cost, with free discreet shipping rolled in. It has no elaborate membership tier, no coaching-heavy wellness platform layered on top and no upsell maze. You get compounded medication delivered cheaply. For a budget-conscious patient who already knows they want a compounded GLP-1 and doesn't need hand-holding, that focus is appealing.
Where the thin disclosure becomes a drawback
Pomegranate publishes very little about the machinery behind the prescription. It does not name its compounding pharmacy publicly, and it publishes no accreditation detail for the pharmacy that fills your order. Better-documented competitors put that front and center. The list of states it serves isn't disclosed on the site either; the company directs prospective patients to email support@joinpomegranate.com to check coverage, and semaglutide doesn't appear to be available in every state. None of this means the operation is unsafe (there are no FDA warning letters on file against it), but "no visible red flags" is not the same as "transparently vetted," and you deserve to know the difference.
Who should choose it, and who should skip it
Choose Pomegranate if cost is your dominant constraint, you're comfortable with compounded medication, and you're willing to do a little legwork (emailing support to confirm your state, reading the current checkout terms) in exchange for a low monthly price. It's a reasonable fit for a returning GLP-1 user who knows the ropes and just wants affordable refills.
Skip it if you want a named, accredited pharmacy you can look up, or if you need brand-name medication. Skip it too if you value built-in coaching, dietitian access, or a polished support experience. Shoppers who care most about coaching or a brand-name option can compare BeyondMD, which includes weight-loss coaching, offers Zepbound and Wegovy consultations and serves all 50 states, though its pharmacies go unnamed too. And skip it if you simply want a provider whose program details are all spelled out before you hand over payment. Patients who need more reassurance about oversight will be more comfortable with a provider that discloses its pharmacy and state coverage up front.
Trust and medical oversight
As a telehealth compounding service, Pomegranate operates in the same regulatory lane as its peers: a clinician review precedes any prescription, and the medication is compounded rather than mass-manufactured. There are no FDA enforcement actions tied to the company. Still, the provider shares very little: no public pharmacy name, no accreditation record, and no published state list. The safety picture is "unremarkable but under-documented" rather than "strongly vouched for."
Bottom line
Pomegranate Health is a price play, and on price it delivers: compounded semaglutide near $129 a month (see plan details) with shipping included is hard to beat, and tirzepatide is competitive too. The cost of that low cost is transparency: you're trusting an operation that keeps its pharmacy, accreditation, and state coverage largely off the page. If you're a confident, budget-first shopper willing to confirm the current price and your state by email, it's a defensible choice. If you want everything documented before you buy, a more openly vetted provider will serve you better.
The Bottom Line
Price is where Pomegranate Health scores best in our breakdown.
Ready to start with Pomegranate Health?
From $129/mo (see plan details). See current pricing and start your free consultation.
Pomegranate Health might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Head-to-head
Compare Pomegranate Health vs…
Pomegranate Health scores7.8/10
Side-by-side pricing, medications and scores. Pick a matchup.
Pomegranate Health vs Amazon One Medical
Amazon One Medical scores 8.5/10

Pomegranate Health vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Pomegranate Health review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Pomegranate Health's current pricing
Plans from $129/mo (see plan details). Start your free consultation to check eligibility and today's price.